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Results: Pts with angina and NCA had decreased Ao strain and Ao dis and
increased Ao stiffness compared with control subjects: Ao Strain 17,7±7,4%
vs 24,8±10,8% (p=0,05), Ao Dis 078 ±0,3 vs 1,2±0,6cm2/dyne (p<0,05), Ao
SI 3,4±1,8 vs 1,9 ±0,5 (p<0,05).
TdI Ao wall velocity were decreased in pts group: SW 6,7±1,6 vs 10±1,9
cm/s, (p<0,05, Anova), EW 5,6±2,1 vs 9,4±2,7 cm/s (p<0,05), AW 7,1±2,3 vs
7,7±2,9 cm/s (p=0,4).
Ea and SVRI were increased and Ca decreased in patients with angina: Ea
2,1±0,5 vs 1,6±0,2 mmHg/ml (p<0,05), SVRI 2,9±0,8 vs 1,9±0,2 dyne *s
*m2/cm-5 (p<0,05), Ca 1,2±0,4 vs 1,6±0,3 ml/mm Hg (p<0,05).
Conclusion: Vascular function proved to be altered in patients with angina
and normal coronary arteries versus control subjects. These findings suggest a
possible pathophysiological link between large arteries stiffening, increased
afterload and angina symptoms, in the absence of coronary stenoses.
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Objective: To evaluate the performance and acceptance of the Screening
CardioVascular Lab (SCVL®, GenNov) as a screening and follow-up tool for
peripheral arterial disease (PAD) in the general practitioner's (GP) office. This
electronic device combines the oscillometric determination of the ankle-bra-
chial index (ABI) and the Edinburgh questionnaire (EQ).
Method: In a cross sectional study, 102 Belgian GPs recruited 505 patients
of 50 years, hospitalized within the last year for any ischemic event. The
electronic case report form was included in the SCVL®. 
Results: The patients were 69±11 years old (m±SD); men were 63%. Their
other CVR factors were: hypertension in 75%; dyslipidemia in 74%; seden-
tarily in 53%; abdominal obesity in 52%; familial history of CVD in 38%;
smoking in 28%; diabetes in 22%. The arterial events, which induced the
recent hospitalizations, were: acute in 71% of cases, planned for revascular-
ization in 23%; coronary in 50%, cerebral in 29%, aortic/peripheral in 15%.
For at least their hospitalization, 95% of patients were treated with antithrom-
botics, including 88% with antiplatelets. At the GP visit, PAD was previously
diagnosed by Doppler ultrasonography or arteriography in 13% of them. The
SCVL® returned the ABIs in 3±1 minutes. The patient ABI was of 0.95±0.20.
The EQ was positive, meaning a symptomatic PAD, in 16% of patients; the
patient ABI, < 0.90 in 37%; their combination, abnormal in 44%. The test sen-
sitivity increased from 64% for the single determination of the patient ABI to
79% for its combination with the EQ, while the specificity decreased from 67
to 61%. The GPs considered the SCVL® as easy-to-use with a score of 76±24/
100 and those experienced with handheld Doppler preferred the SCVL® with
a score of 73±30/100.
Conclusion: By automating combination of the oscillometric ABI and of
the Edinburgh questionnaire, the SCVL® emerges as an efficient and easy-to-
use device for the screening and follow-up of PAD by the GPs.
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Objective: To improve arterial rigidity in coronary patients
Methods: 48 coronary patients: 57 yrs; 15% women were compared with
16 volunteers: 51 yrs. Patients were included in a 4-week ambulatory educa-
tional program consisted of 22 meetings of cardiac rehabilitation, a therapeutic
and dietetic education and drugs adaptation following european recommanda-
tions. Patients and volunteers were examined at the beginning (Day 0 and 1),
at the end of the program (M1) and at 6 months. Brachial (average of 3 mea-
surements by OMRON M4) and central BP, pulse wave velocity (Sphyg-
mocor), heart rate, cholesterol, weight, smoking addiction and drug intake
were analysed by the same nurse. BP and PWV measurements at D1 were
used as baseline values. Percentage of variation for PWV between D1 and M1
for the volunteers was 6%.
Results: At M6 vs D1, patients risk factors were improved: total choles-
terol <5 mmol/l: 89 vs 50%, BP-140/90 mmHg: 96 vs 81%, smoking addic-
tion: 12.5 vs 15%, obesity (BMI>30): 15 vs 19%, diabete: 6% and
recommended treatment: 58% with beta blockers:79%, Aspirin: 100%, Statin:
96%, ACEI or sartan: 75%
Table – Results
Heart rate did not change significantly. The most important parameter to
explain the decrease of patients PWV was central BP after multiple regression.
Treatment did not significantly modify PWV, nor smoking addiction or total
cholesterol control (Student t test).
Conclusion: The education in a health network improved CV risk factors
and recommended treatment but also arterial rigidity in a few weeks. This
improvement was maintained although BP increased at M6 and heart rate did
not change during the study. This depends probably on an intrinsic improve-
ment of arterial rigidity of these coronary patients
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Objectives: the aims of our study were to assess the prevalence of signif-
icant lower limb arterial stenosis in a population of patients with an increased
cardiovascular risk and also to determine the best ankle brachial index
threshold value for its detection.
Methods: In patients with treated hypertension and/or another cardiovas-
cular risk factor (dyslipidemia, current smoking, diabetes), ankle brachial
index was measured using an automated oscillometric device with 2 synchro-
nized cuffs. The presence of atherosclerotic plaques was assessed indepen-
dently by a Doppler/ultrasound exam.
Results: We included 201 patients. Fifty two percent were men, of 58
±13,4 years old. Fifty 6 percent were treated for hypertension, 72% had dys-
lipidemia and 23% were treated for diabetes. There was 21% of current
smokers and 33% of previous smokers. A clinical peripheral arterial disease
was noted in 7% of the patients and the presence of a femoral stenosis >50%
in 7.7%. The prevalence of an ankle brachial index <0,9 was 19,7% and
16.6% for an ankle brachial index <0,85. The ankle brachial index perfor-
mance to detect a significant femoral plaque or a clinical peripheral arterial
disease is detailed in the table. The best predictors of the presence a peripheral
arterial disease or a significant plaque are one of the 3 following ankle bra-
chial index values: <0,85 or >1,30 or missing signal.
Conclusion: In patients with increased cardiovascular risk, the prevalence
of a significant inferior limb stenosis is 7.7%. The ankle brachial index is
easily and quickly measured by the automated SCVL® device. Our study
attests the feasibility of this approach to detect peripheral arterial disease and
arterial stenosis in daily practice in this population. 
Patients results: (mean) D1 M1 M6
Brachial BP (mmHg) 119/68 114/66* vs D1 122/69* vs M1
Central BP (mmHg) 110/69 106/66*vs D1 112/69*vs M1
PWV (m/s) 9.76 9.40*vs D1 9.42vs D1 (p: 0.057)
Volunteers results: (mean) D1 M1
Brachial BP (mmHg) 116/70 115/69
PWV (m/s) 8.6 8.8
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Table – Results
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Context: Atherothrombotic cardiovascular disease has both functional and
anatomic components that can be assessed non invasively.
Objectif: To compare arterial properties after two different acute athero-
thrombotic event.
Design, setting, patients: Usual cardiovascular risk factors, carotid param-
eters, pulse wave velocity, brachial flow mediated dilatation and ambulatory
blood pressure monitoring were assessed in a cohort of 100 patients who pre-
sented either acute coronary syndrome (Group 1, N=50) or ischemic athero-
thrombotic stroke (Group 2, N=50) matched for age and gender.
Main outcome: Differences of arterial properties according to the type of
acute vascular events.
Results: History of hypertension, diabetes, dyslipidemia, cardiovascular
heredity, smoking and body mass index were similar in both groups. All blood
pressure parameters (clinic and 24-hour ambulatory blood pressure moni-
toring) were higher in group 2 (p<0.01). Metabolic abnormalities were more
often experienced after an acute coronary syndrome, with higher prevalence in
metabolic syndrome (28% vs. 10%, p=0.02) and higher triglycerides
(1.76±0.91 vs. 1.36±0.68 mmol/l, p=0.02) and glucose levels (5.89±2.16 vs.
4.92±0.74 mmol/l, p=0.003). Carotid intima-media thickness and carotid-to-
femoral pulse wave velocity were significantly higher in group 2 than group 1
(769±180 vs. 701±136 μm, p=0.03; 12.5±3.5 vs.10.7±2.4 m/s, p=0.006). Prev-
alence of endothelial dysfunction and carotid plaques were similar in acute
coronary syndrome and ischemic atherothrombotic stroke group (86% vs.
74%, p=NS and 80% vs. 78%, p=NS, respectively).
Conclusion: In stroke patients, aortic stiffness and carotid wall thickness were
higher than in acute coronary syndrome patients. These structural and functional
differences may have a direct involvement in the occurrence of the event.
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Aim: To assess immediate and midterm outcomes of a systematic endovas-
cular approach for the treatment of lower limb ischemia following the use of
vascular closure devices (VCD) after percutaneous coronary and peripheral
interventional procedures.
Methods: From January 2006 to December 2008, all the patients who
developed lower limb ischemia following the use of a VCD in a single high
volume French institution were systematically managed percutaneously and
constituted the population of this study. Clinical characteristics, immediate
and midterm outcomes are reported.
Results: 18 patients (3 males and 15 females) were included. Mean age
was 67.1 years. Closure devices were Angio-seal* in 12 cases, Starclose* in 3
cases and Perclose* in 3 cases. On average, lower limb ischemia occurred 6.5
days (range 1-28 days) after device placement. Culprit lesion was located in
the left common femoral artery in 6 cases and in the right common femoral
artery in 12 cases. Secondary vascular access was obtained through the
humeral artery in 12 cases and the controlateral femoral artery in 6 cases. A
90 cm-long 6F Destination* guiding sheath was used in 13 cases and a 6F
multipurpose guiding catheter in the remainder. The occlusion site was suc-
cessfully crossed in all cases using 0.014 inch coronary guidewires in 8 cases
and a hydrophilic 0.035 inch Terumo glidewire in 8 cases. 12 patients were
treated with balloon angioplasty and 6 with stent implantation. Angiographic
success was obtained in all the cases. After a mean 27.3 months follow-up,
only two patients initially treated by PTA needed re-intervention (due to
symptomatic restenosis ) consisting in a balloon angioplasty in one case and
stent implantation in the second case (after respectively 3 and 4 months). At
final follow-up, all the patients were asymptomatic
Conclusion: Endovascular treatment for VCD-related limb ischemia is a
feasible and efficient approach resulting in excellent immediate and mid-term
outcomes
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Introduction: Heart rate variability (HRV) and heart rate turbulence
(HRT) are valuable non invasive methods determining quantitatively the sym-
pathetic and parasympathetic modulations of heart rate. The variation of HRV
and HRT may be influenced by clinical parameters.
Aim: the aim of this study is to evaluate the impact of body mass index
(BMI) on HRV and HRT in hypertensive patients.
Methods: 85 patients with hypertension (mean age 57±11 years) under-
went 24 hour Holter recording. The following HRV parameters were studied:
(SDNN, SDNN5, RMSSD, BF, HF and BF/HF). HRT parameters were also
analysed (TO and TS). Patients were divided in three groups according to their
BMI:. group 1: BMI<25 kg/cm², group 2: BMI between 25 and 30 kg/cm² and
group 3: BMI>30 kg/cm².
Resultats: HRV and HRT parameters were comparable in the three groups
Table. Parameters of HRV and HRT according to BMI
Sensibility 
(%) 
Specificity 
(%) 
Positive 
predictive 
value (%) 
Negative 
predictive 
value (%)
ABI<0.9 83.3 84.5 26.3 98.7
ABI<0.9 or >1.3 
or missing signal
93.3 83.4 31.8 99.3
ABI <0.85 83.3 87.8 31.3 98.8
ABI <0.85 or >1.35 
or missing signal
93.3 87.3 37.8 99.4
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Group 1
(n=13)
Group 2
(n=43)
Group 3
(n=29)
Grp 1
Vs 2
p
Grp 1
Vs 3
p
Grp 2 
Vs 3
p
SDNN 99±28 122±33 116±34 NS NS NS
SDNN 5 49±19 54±16 51±22 NS NS NS
RMSSD 35±25 38±22 38±23 NS NS NS
BF 545±47 596±55 523±55 NS NS NS
HF 308±36 323±36 264±31 NS NS NS
BF/HF 2.41±1.1 2.94±1.9 2.47±1.4 NS NS NS
TO –0.022 –0.024 –0.013 NS NS NS
TS 13.26 7.21 8.25 NS NS NS
